Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-3.94	18.86	19.63
Graham Fair Price	96.75	47.19	23.99
PEG	0.00	0.00	0.00
Price/Book	-5.64	1.50	1.59
Price/Cash Flow	868.64	130.81	13.50
Prices/Earnings	-73.76	6.70	25.52
Price/Sales	-1.44	3.66	3.71
Price/FCF	868.64	130.81	13.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	107.23	0.33	0.16
Operating Margin	4.77	0.17	0.16
ROA	268.97	0.03	< 0.005
ROE	0.02	0.06	259.60
ROIC	0.01	0.04	205.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	13.47	12.12	-10.02
Days Sales Outstanding (DSO)	28.01	31.56	12.69
Inventory Turnover	6.68	7.43	11.14
Debt/Capitalization	0.38	0.37	-2.31
Quick Ratio	0.44	0.61	36.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	40.50	44.40	9.62
Cash	2.06	2.13	3.64
Capex	-2.64	3.04	15.31
Free Cash Flow	4.77	0.48	-89.89
Revenue	17.36	17.25	-0.67
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	0.63	0.70	10.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.12	5.07	-0.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating